Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Oaktree

24 Apr 2018 14:58

RNS Number : 9735L
Ranger Direct Lending Fund PLC
24 April 2018
 

24 April 2018

For immediate release

 

 

Ranger Direct Lending Fund plc

("Ranger" or the "Company")

 

Response to Oaktree

 

The Board notes today that Oaktree Capital Management, L.P. ("Oaktree"). has publicly released private correspondence between itself and the Board of Ranger.

 

On 29 January 2018 the Company announced that an independent committee of the Board was conducting a review of the Company's future investment management arrangements and that an Independent Valuer had been appointed to value the Company's portfolio other than the Princeton assets (together, the "Review Process").

 

The Company notes that Oaktree's announcement today merely publishes their letter dated Wednesday 11th April 2018 in which they relayed the "conclusion" that a winding down was the best way forward for the Company. Since the receipt of Oaktree's letter, the Company and its advisors have communicated to Oaktree that all of the relevant issues raised by Oaktree are already being dealt with as part of the Review Process. The only conclusion which can be drawn from this sequence of events is that Oaktree had no serious interest in engaging in the Review Process and their course of action was solely driven by their short-term considerations.

 

With the Review Process completed on schedule, the Board is now engaged in an active and positive discussion with shareholders regarding the future of the Company (including addressing the issues raised in the Oaktree announcement), ahead of the publication of the findings. It is essential to the future of Ranger as a successful public company to achieve sufficient consensus between the Board and shareholders on the Company's future direction. To deliver this outcome requires a detailed and measured dialogue with shareholders.

 

The Company has obligations to its ZDP shareholders. Oaktree's announcement today offers no detail on how those obligations would be met. During a dialogue with Oaktree on 23rd April 2018, in answer to specific requests for information, Oaktree and its advisors were unable to offer the Company any information of substance around a plan for dealing with the contractual rights of the ZDP shareholders or balancing these interests with Ordinary Shareholders.

 

The Review Process has considered the possibility of a full or partial winding down of the Company's activities and returning cash to shareholders. The Board has a duty to act in the interests of all shareholders and, therefore, must seek to achieve the best capital value for the Company's assets and protect dividend flows. In the view of the Board, Oaktree's approach will accomplish neither of those objectives and lead to an extended period of uncertainty for shareholders. In respect of capital value and dividend flows the Board reiterates its view that Oaktree's approach is driven by its own short-term interests.

 

As noted above, the Board's findings on the Review Process including manager selection and investment policy and the independent valuation of the portfolio (other than the Princeton assets) will be published shortly.

 

Contacts:

 

Ranger Direct Lending Fund plc

Christopher Waldron (Chairman)

 

Via Kinmont

Kinmont

Gavin Kelly

 

Tel: +44 (0)20 7087 9134

 

Liberum

Joshua Hughes

 

Tel: +44 (0)20 3100 2000

Redleaf (for media enquiries)

Robin Tozer

Tel: + 44 (0) 20 3757 6867

ranger@redleafpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPFKQDPNBKDQQB
Date   Source Headline
5th May 201610:33 amRNSCorrection: Interim Dividend
5th May 20167:00 amRNSInterim Dividend
21st Apr 20162:49 pmRNSMonthly Update
21st Apr 20162:42 pmRNSNet Asset Value(s)
15th Apr 20167:00 amRNSNotice of AGM
1st Apr 20164:36 pmRNSMonthly Update
1st Apr 20164:32 pmRNSNet Asset Value(s)
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:36 pmRNSPrice Monitoring Extension
9th Mar 20164:20 pmRNSEnd of Year Update
3rd Mar 20163:08 pmRNSMonthly Update
3rd Mar 20162:47 pmRNSNet Asset Value(s)
24th Feb 20166:21 pmRNSInterim Dividend
1st Feb 20169:14 amRNSMonthly Update
1st Feb 20169:05 amRNSNet Asset Value(s)
29th Jan 20164:22 pmRNSResult of AGM
4th Jan 20164:43 pmRNSTotal Voting Rights
30th Dec 20151:27 pmRNSMonthly Update
30th Dec 20151:24 pmRNSNet Asset Value(s)
21st Dec 20154:00 pmRNSNotice of AGM
17th Dec 20153:33 pmRNSHolding(s) in Company
16th Dec 20157:00 amRNSAdmission to Trading of New Ordinary Shares
11th Dec 20159:52 amRNSTap Issue Update
4th Dec 20153:54 pmRNSClose of Tap Issue
4th Dec 201510:24 amRNSTap Issue
27th Nov 20154:21 pmRNSMonthly Update
27th Nov 20154:15 pmRNSNet Asset Value(s)
26th Nov 20152:47 pmRNSCompany Update
19th Nov 20152:45 pmRNSHolding(s) in Company
16th Nov 20152:46 pmRNSC Share Issue
13th Nov 20159:46 amRNSCorporate Update
11th Nov 20152:56 pmRNSInterim Dividend
10th Nov 20157:00 amRNSC Share Issue
6th Nov 20151:41 pmRNSInterest Streaming Election
26th Oct 20151:49 pmRNSMonthly Update
26th Oct 20151:40 pmRNSNet Asset Value(s)
22nd Oct 20152:02 pmRNSHolding(s) in Company
21st Oct 20155:10 pmRNSHolding(s) in Company
12th Oct 20157:00 amRNSCorporate Update
8th Oct 20154:08 pmRNSHolding(s) in Company
24th Sep 20152:20 pmRNSMonthly Update
24th Sep 20152:17 pmRNSNet Asset Value(s)
26th Aug 20156:23 pmRNSMonthly Update
26th Aug 20156:18 pmRNSNet Asset Value(s)
12th Aug 20157:00 amRNSHalf Yearly Report
22nd Jul 20152:59 pmRNSMonthly Update
22nd Jul 20152:55 pmRNSNet Asset Value(s)
29th Jun 201511:42 amRNSHolding(s) in Company
24th Jun 20151:30 pmRNSEligibility for ISA inclusion
17th Jun 20155:17 pmRNSMonthly Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.